
zzso zzso zzso and zzso zzso cells zzso inhibit zzso immune responses and facilitate tumor zzso zzso for these immune cell populations migrate to the tumor site in response to tumor zzso of zzso such as zzso zzso zzso zzso which was originally zzso and identified from human zzso In zzso mouse zzso zzso and human zzso zzso zzso models, we evaluated the efficacy of systemic zzso blockade by zzso zzso zzso targeting mouse and/or human zzso zzso zzso administration of zzso zzso zzso as zzso (2 zzso twice a week) significantly, albeit zzso prolonged the survival of zzso mice bearing zzso zzso zzso zzso zzso zzso which was zzso with a decrease in zzso and zzso in the tumor zzso Similarly, survival was modestly prolonged in severe combined zzso mice bearing zzso human zzso zzso zzso treated with both zzso zzso zzso and zzso zzso zzso (2 zzso for each, twice a week) compared to mice treated with control zzso zzso zzso zzso Furthermore, zzso administration of zzso zzso zzso in combination with zzso zzso significantly prolonged the survival of zzso mice bearing zzso zzso with 8 of 10 treated mice surviving longer than 70 days, while only 3 of 10 mice treated with zzso and zzso zzso survived longer than 70 days zzso zzso zzso These observations provide support for development of zzso zzso blockade strategies in combination with the current standard zzso chemotherapy for treatment of zzso zzso 

